Senior Director, Commercial Learning & Development at Cytokinetics
📍 Philadelphia, Pennsylvania, United States
Spencer Curtis is the Senior Director of Commercial Learning & Development at Cytokinetics, with extensive experience from senior roles at Otsuka Pharmaceutical and Bristol-Myers Squibb. He specializes in merging tactical planning with biotechnology ventures and has a background in business excellence from Columbia Business School.
Outside of his corporate roles, Spencer is passionate about professional growth and making meaningful connections. He actively engages in mentoring programs and shows a keen interest in the principles of authentic leadership, as highlighted by his public appreciation for content on the topic.
He has signed up for the Cyto Exchange 2025 program with the goal of mentoring, sharing, and learning with other professionals.
Read the full overview →
Current Role
Senior Director, Commercial Learning & Development
Location
Philadelphia, Pennsylvania, United States
Personality Overview
How Spencer shows up
Not Easily Convinced
Price-Sensitive
Value Seeker
They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. It is quite likely of them to ask for pricing or other concessions.
Priorities
Topics Spencer cares about
Commercial Leadership
Holds senior commercial and business director roles at Cytokinetics and Otsuka, focusing on learning, development, and strategic planning in the pharmaceutical industry.
Biotechnology Ventures
His work involves merging tactical planning with the ambitious objectives of biotechnology ventures to establish a robust market presence and deliver impactful healthcare solutions.
+5 more topicsLogin to view topics
Career
Work history
12-2024
Senior Director, Commercial Learning & Development
Cytokinetics
5-2023 - 12-2024
Senior Business Director- Tristate Region
Otsuka Pharmaceutical Companies (U.S.)
5-2021 - 5-2023
Head of Digital Portfolio Strategy
Otsuka Pharmaceutical Companies (U.S.)
10-2020 - 5-2021
Senior Director, CNS Portfolio Strategy and Asset Management
Otsuka Pharmaceutical Companies (U.S.)
1-2020 - 10-2020
Director, US Oncology Franchise Marketing Strategy & Operations
Bristol-Myers Squibb
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Other Cytokinetics Employees
Explore more public profiles from related professionals.